Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 2/20 | 0.57 |
| ▸ | FGFR1 | P11362 | 12/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17656036 | 0.93 | KDR (0.53) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655829 | 0.93 | KDR (0.53) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655958 | 0.91 | KDR (0.55) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL18965400 | 0.90 | KDR (0.54) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL27285256 | 0.88 | KDR (0.63) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655886 | 0.88 | KDR (0.50) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655920 | 0.88 | KDR (0.50) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655940 | 0.88 | KDR (0.50) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655827 | 0.88 | KDR (0.50) | KDRFGFR1MAPTKMT2APTK2B | |
| SCHEMBL17655980 | 0.86 | KDR (0.61) | KDRFGFR1MAPTKMT2APTK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021049840-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-03-18 | — | — | WO | disclosed |